DAKOTA COOK: Open Payments
NPI 1902486780 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $168 |
| Boston Scientific Corporation | 1 | $143 |
| Corcept Therapeutics | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: OverStitch NXT Endoscopic Suturing System, UBRELVY, Korlym, VRAYLAR, REXULTI, QULIPTA, Rybelsus, Kerendia.
Industry payments across NE — which companies pay providers there.
